Cargando…

Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India

BACKGROUND: Clinical phenotypes of patients with antibodies to myelin oligodendrocyte glycoprotein (anti-MOG+) are unknown in India. OBJECTIVES: Retrospectively to characterise anti-MOG+ patients with inflammatory central nervous system disorders in India. METHOD: A total of 87 patients with non-mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandit, Lekha, Sato, Douglas Kazutoshi, Mustafa, Sharik, Takahashi, Toshiyuki, D’Cunha, Anitha, Malli, Chaithra, Sudhir, Akshatha, Fujihara, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433499/
https://www.ncbi.nlm.nih.gov/pubmed/28607742
http://dx.doi.org/10.1177/2055217316675634
_version_ 1783236869162532864
author Pandit, Lekha
Sato, Douglas Kazutoshi
Mustafa, Sharik
Takahashi, Toshiyuki
D’Cunha, Anitha
Malli, Chaithra
Sudhir, Akshatha
Fujihara, Kazuo
author_facet Pandit, Lekha
Sato, Douglas Kazutoshi
Mustafa, Sharik
Takahashi, Toshiyuki
D’Cunha, Anitha
Malli, Chaithra
Sudhir, Akshatha
Fujihara, Kazuo
author_sort Pandit, Lekha
collection PubMed
description BACKGROUND: Clinical phenotypes of patients with antibodies to myelin oligodendrocyte glycoprotein (anti-MOG+) are unknown in India. OBJECTIVES: Retrospectively to characterise anti-MOG+ patients with inflammatory central nervous system disorders in India. METHOD: A total of 87 patients with non-multiple sclerosis demyelinating disorders (excluding acute disseminated encephalomyelitis) who were seronegative for anti-aquaporin 4 antibody were retrospectively analysed using a cell-based assay for anti-MOG+ status. RESULTS: Twenty-five patients were anti-MOG+ in this cohort. They represented 28.7% (25/87) of patients who tested negative for anti-AQP4+. Sixty-four per cent (16/25) of anti-MOG+ patients were men and had a relapsing course. Patients with recurrent optic neuritis and those with a single attack of acute longitudinally extensive transverse myelitis were the most common phenotypes. CONCLUSION: Relapsing optic neuritis was the most common phenotype, contrasting with a lower risk of relapses in transverse myelitis.
format Online
Article
Text
id pubmed-5433499
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-54334992017-06-12 Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India Pandit, Lekha Sato, Douglas Kazutoshi Mustafa, Sharik Takahashi, Toshiyuki D’Cunha, Anitha Malli, Chaithra Sudhir, Akshatha Fujihara, Kazuo Mult Scler J Exp Transl Clin Short Report BACKGROUND: Clinical phenotypes of patients with antibodies to myelin oligodendrocyte glycoprotein (anti-MOG+) are unknown in India. OBJECTIVES: Retrospectively to characterise anti-MOG+ patients with inflammatory central nervous system disorders in India. METHOD: A total of 87 patients with non-multiple sclerosis demyelinating disorders (excluding acute disseminated encephalomyelitis) who were seronegative for anti-aquaporin 4 antibody were retrospectively analysed using a cell-based assay for anti-MOG+ status. RESULTS: Twenty-five patients were anti-MOG+ in this cohort. They represented 28.7% (25/87) of patients who tested negative for anti-AQP4+. Sixty-four per cent (16/25) of anti-MOG+ patients were men and had a relapsing course. Patients with recurrent optic neuritis and those with a single attack of acute longitudinally extensive transverse myelitis were the most common phenotypes. CONCLUSION: Relapsing optic neuritis was the most common phenotype, contrasting with a lower risk of relapses in transverse myelitis. SAGE Publications 2016-10-24 /pmc/articles/PMC5433499/ /pubmed/28607742 http://dx.doi.org/10.1177/2055217316675634 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Short Report
Pandit, Lekha
Sato, Douglas Kazutoshi
Mustafa, Sharik
Takahashi, Toshiyuki
D’Cunha, Anitha
Malli, Chaithra
Sudhir, Akshatha
Fujihara, Kazuo
Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India
title Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India
title_full Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India
title_fullStr Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India
title_full_unstemmed Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India
title_short Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India
title_sort relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in india
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433499/
https://www.ncbi.nlm.nih.gov/pubmed/28607742
http://dx.doi.org/10.1177/2055217316675634
work_keys_str_mv AT panditlekha relapsingopticneuritisandisolatedtransversemyelitisarethepredominantclinicalphenotypesforpatientswithantibodiestomyelinoligodendrocyteglycoproteininindia
AT satodouglaskazutoshi relapsingopticneuritisandisolatedtransversemyelitisarethepredominantclinicalphenotypesforpatientswithantibodiestomyelinoligodendrocyteglycoproteininindia
AT mustafasharik relapsingopticneuritisandisolatedtransversemyelitisarethepredominantclinicalphenotypesforpatientswithantibodiestomyelinoligodendrocyteglycoproteininindia
AT takahashitoshiyuki relapsingopticneuritisandisolatedtransversemyelitisarethepredominantclinicalphenotypesforpatientswithantibodiestomyelinoligodendrocyteglycoproteininindia
AT dcunhaanitha relapsingopticneuritisandisolatedtransversemyelitisarethepredominantclinicalphenotypesforpatientswithantibodiestomyelinoligodendrocyteglycoproteininindia
AT mallichaithra relapsingopticneuritisandisolatedtransversemyelitisarethepredominantclinicalphenotypesforpatientswithantibodiestomyelinoligodendrocyteglycoproteininindia
AT sudhirakshatha relapsingopticneuritisandisolatedtransversemyelitisarethepredominantclinicalphenotypesforpatientswithantibodiestomyelinoligodendrocyteglycoproteininindia
AT fujiharakazuo relapsingopticneuritisandisolatedtransversemyelitisarethepredominantclinicalphenotypesforpatientswithantibodiestomyelinoligodendrocyteglycoproteininindia